Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
B1037 AlvelestatTarget: NESummary: NE inhibitor
-
A4432 ARP 1001 CitationTarget: MMPSummary: Selective MMP-2 inhibitor
-
A4430 Sivelestat sodium saltTarget: ElastasesSummary: Leukocyte elastase inhibitor
-
A4431 SSR 69071Summary: HLE inhibitor
-
B6189 Sivelestat (ONO-5046)Summary: neutrophil elastase inhibitor
-
C3252 Neutrophil Elastase InhibitorSummary: neutrophil elastase inhibitor
-
C3609 (Z-Ala-Ala-Ala-Ala)2Rh110Summary: fluorogenic elastase substrate
-
C4325 BAY-678Summary: HNE inhibitor
-
B4675 GW311616Summary: inhibitor of human neutrophil elastase(HNE)
-
B4676 GW311616 hydrochlorideSummary: HNE inhibitor